Access and coverage dynamics
Medicaid remains a central element of coverage strategy, with states using waivers and targeted program changes to manage enrollment and benefits. Ongoing redetermination processes have increased churn in coverage for many low-income households, highlighting the importance of streamlined renewal procedures and outreach. At the same time, the private market continues to evolve: Medicare Advantage enrollment has grown, prompting closer regulatory scrutiny of benefit design and prior authorization practices.
Cost control and prescription drugs
Drug pricing is a top policy focus. Efforts to lower out-of-pocket costs include negotiation mechanisms, inflation-linked rebates, and initiatives to increase pricing transparency. Policymakers and agencies are also exploring ways to expand biosimilars and generics to reduce spending. Employers and insurers are testing benefit design strategies—such as value-based formularies and site-of-care programs—to discourage high-cost utilization without eroding access.
Value-based care and payment reform
The shift from fee-for-service to value-based payment models continues to accelerate.
Accountable care organizations, bundled payments, and other alternative payment models aim to align incentives around outcomes rather than volume. Providers investing in care management, data analytics, and population health are positioned to benefit, while smaller practices face challenges adapting to new reporting and financial risk requirements.
Telehealth, digital health, and interoperability
Telehealth adoption remains a durable change following rapid expansion, but permanent policy frameworks are still being refined. Coverage parity, cross-state licensure, and reimbursement rates are key unresolved issues. Concurrently, advances in interoperability and data sharing—driven by regulatory requirements and industry initiatives—are unlocking opportunities for care coordination, but patient privacy and cybersecurity remain critical concerns.
Health equity and maternal health
Reducing disparities is a cross-cutting policy priority. Maternal mortality and morbidity, particularly among underserved communities, have prompted targeted programs to expand prenatal and postpartum services, strengthen Medicaid coverage around childbirth, and support community-based interventions. Addressing social determinants of health through Medicaid waivers, Section 1115 demonstrations, and value-based contracts is increasingly common.
Workforce and behavioral health
Clinician shortage and burnout continue to constrain capacity, especially in primary care, rural areas, and behavioral health. Policy responses include expanding loan repayment programs, supporting training pipelines, and credentialing reforms to leverage nonphysician clinicians. Behavioral health integration into primary care and tele–mental health reimbursement improvements are helping to close gaps, though demand still outstrips supply.
Regulatory enforcement and market consolidation
Regulators are paying closer attention to hospital and insurer consolidation, with enforcement actions targeting anticompetitive mergers that could raise prices. Price transparency rules are also under active enforcement, as payers and providers adapt to requirements to disclose negotiated rates and out-of-pocket costs.
What to watch next
– Rulemaking from federal agencies on telehealth, interoperability, and drug pricing mechanisms.
– State Medicaid policy choices around eligibility, benefits, and care delivery models.
– Enforcement activity related to surprise billing, price transparency, and mergers.
– Expansion of value-based payment arrangements and their impact on small practices.
– Policy efforts aimed at workforce expansion and behavioral health access.
For providers, payers, and advocates, staying engaged in rulemaking, investing in data and care-management infrastructure, and prioritizing equity-focused interventions will be essential to navigate this evolving policy environment. Consumers should monitor coverage notices, understand their plan’s telehealth and drug cost protections, and engage local representatives on priorities like affordability and access.